News
SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX ... and R529 to its list of antibacterial products in clinical development for priority pathogens, recognising Recce ...
SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX ... The World Health Organization (WHO) added R327, R435, and R529 to its list of antibacterial products in clinical ...
SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX ... The World Health Organization (WHO) added R327, R435, and R529 to its list of antibacterial products in clinical ...
MIRA Pharmaceuticals (MIRA ... and testing parameters followed FDA-recommended guidance for topical product evaluation. MIRA is currently advancing preclinical studies to evaluate the topical ...
PBZ OTC Pyribenzamine Antihistamine Cream, the first new topical ... as a 2025 Product of the Year winner in the Immediate Relief category," said Benjamin Blessing, COO of Kingsway Pharmaceuticals.
For too long, families have relied on the same limited options for topical ... Product of the Year winner in the Immediate Relief category," said Benjamin Blessing, COO of Kingsway Pharmaceuticals.
PBZ OTC Pyribenzamine Antihistamine Cream, the first new topical antihistamine ... by consumers as a 2025 Product of the Year winner in the Immediate Relief category," said Benjamin Blessing, COO of ...
5don MSN
A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...
Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life. Acne-like skin rash is a common side effect from ...
The US Food and Drug Administration (FDA) said Tuesday it has become aware of reports of adverse events associated with compounded topical finasteride products, and it has issued an alert for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results